Sri Jagan Medicals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 15 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.00 M
as on 24-10-2024
- Revenue 48.12%
(FY 2023)
- Profit 3.57%
(FY 2023)
- Ebitda 6.18%
(FY 2023)
- Net Worth 16.95%
(FY 2023)
- Total Assets 30.67%
(FY 2023)
About Sri Jagan Medicals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.00 M.
Sunil Pawar and Asha Rani serve as directors at the Company.
- CIN/LLPIN
U24232DL2009PTC188751
- Company No.
188751
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Mar 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Sri Jagan Medicals Private Limited offer?
Sri Jagan Medicals Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Blood Bank Equipments, Hospital Bed and Mattress, ICU Beds, Semi Fowler Beds, CPAP, BiPAP Machine & Accessories, BiPAP Machine, Autoclaves, Sterilizers & Incubators, Medical Refrigerator Systems, Medical Equipment & Accessories.
Who are the key members and board of directors at Sri Jagan Medicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Pawar  | Director | 24-Mar-2009 | Current |
| Asha Rani | Director | 17-Feb-2011 | Current |
Financial Performance of Sri Jagan Medicals.
Sri Jagan Medicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 48.12% increase. The company also saw a slight improvement in profitability, with a 3.57% increase in profit. The company's net worth Soared by an impressive increase of 16.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sri Jagan Medicals?
In 2023, Sri Jagan Medicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 14 Jun 2024 | ₹6.00 M | Open |
How Many Employees Work at Sri Jagan Medicals?
Unlock and access historical data on people associated with Sri Jagan Medicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sri Jagan Medicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Jagan Medicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
